Brain signature of resilience suggests a new way to recovery from trauma

Researchers at UCSF find a brain signature of resilience in mice that suggests a new way of treating severe depression.

IDRx raises $120m to fund gastric tumour trials for lead TKI therapy

In 2022, IDRx raised $122m in Series A financing and licensed two TKI inhibitors – IDRX-42 from Merck KGaA, and IDRX-73 from Blueprint Medicines. Image

August 7, 2024

Dexcom, Hologic picked to outperform in 2024: William Blair

Listen to the article 5 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: William Blair analysts have selected

December 7, 2023

Visible light technique simplifies synthesis of key pharmaceutical building blocks

University of Michigan chemists have discovered a way to use visible light to synthesize a class of compounds particularly well suited for use in pharmaceuticals.

July 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.